Blue Trust Inc. Sells 856 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Blue Trust Inc. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 36.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,478 shares of the company’s stock after selling 856 shares during the quarter. Blue Trust Inc.’s holdings in GE HealthCare Technologies were worth $116,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. LGT Financial Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. Capital Performance Advisors LLP bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC grew its stake in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on GEHC. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $91.09 on Friday. The business has a 50 day moving average of $85.05 and a 200-day moving average of $85.83. The firm has a market cap of $41.66 billion, a PE ratio of 21.04, a P/E/G ratio of 3.20 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.